Ming-Ching Lee

Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival

Hideki Ujiie, Kyuichi Kadota, Jamie E. Chaft et al. · Journal of Clinical Oncology · 2015 · 233 citations · Full text

Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non–Small-Cell Lung Cancer: A Competing Risks Analysis

Takashi Eguchi, Sarina Bains, Ming-Ching Lee et al. · Journal of Clinical Oncology · 2016 · 201 citations · Full text

Acute Lung Injury, Surgical Oncology, Risks Analysis +24

Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2

Min‐Che Tung, Po-Lin Lin, Yao-Chen Wang et al. · Oncotarget · 2015 · 136 citations · Full text

Cisplatin Resistance, Tumor Biology, Oncogenic Agent +15

A chiral carbazole based sensor for sequential “on-off-on” fluorescence detection of Fe3+ and tryptophan/histidine

Arul Pundi, Chi‐Jung Chang, Jem-Kun Chen et al. · Sensors and Actuators B Chemical · 2020 · 98 citations

Engineering, Biochemistry, Biosensing Systems +7

cIAP2 Upregulated by E6 Oncoprotein via Epidermal Growth Factor Receptor/Phosphatidylinositol 3-Kinase/AKT Pathway Confers Resistance to Cisplatin in Human Papillomavirus 16/18–Infected Lung Cancer

Heng-Hsiung Wu, Jeng-Yuan Wu, Ya‐Wen Cheng et al. · Clinical Cancer Research · 2010 · 74 citations · Full text